Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Prudential Financial reportedly considering sale of Indian asset management business

Prudential Financial reportedly considering sale of Indian asset management business

格隆汇格隆汇2026/01/12 04:35
Show original
By:格隆汇
Glonghui January 12|According to sources familiar with the matter, the investment management subsidiary under Prudential Financial Group is considering selling its loss-making asset management business in India, which it acquired from Deutsche Bank a decade ago. The sources said that PGIM Inc., the investment management arm of Prudential Financial, has hired Ernst & Young to provide advisory services regarding the potential sale of its asset management subsidiary in India. The sources requested anonymity as the discussions involve non-public information. According to these sources, the sale of PGIM India Asset Management Pvt Ltd. is being advanced after its parent company assessed the growth of the division. The subsidiary currently manages approximately 266 billion rupees (3 billion USD) in assets. In recent years, the subsidiary has seen little substantial expansion.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Record High Monthly Active Users Can't Hide Risks: Pinterest (PINS.US) Q3 Revenue and Profit Both Miss Expectations, Q4 Guidance Weak, Shares Drop Over 10% After Hours

Pinterest (PINS.US), the image-based social networking and shopping platform, released its Q3 2026 financial report on Thursday, October 29 local time. Although global monthly active users (MAU) reached a historic high of 661 million and net sales achieved double-digit growth, both the company's revenue and adjusted profit for the quarter fell short of Wall Street expectations.

智通财经•2026/10/29 23:11

Core business achieves fastest growth in over a decade! Gilead (GILD.US) Q3 is a mix of good and bad news: Raises full-year sales guidance but Biktarvy will face a 38% price cut pressure from U.S. Medicare

On October 29th (Thursday) local time, US biopharmaceutical giant Gilead Sciences (GILD.US) released its financial report for the third quarter of 2026. Driven by double-digit growth in its flagship HIV drug portfolio, the company's product sales in the quarter increased by 13% year-over-year to $8.3 billion, surpassing market expectations.

智通财经•2026/10/29 22:56